These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 14752775)

  • 1. Umbilical cord blood transplantation in adults using myeloablative and nonmyeloablative preparative regimens.
    Koh LP; Chao NJ
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):1-22. PubMed ID: 14752775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical cord blood transplantation--how, when and for whom?
    Cohen Y; Nagler A
    Blood Rev; 2004 Sep; 18(3):167-79. PubMed ID: 15183901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical cord blood transplantation in adult myeloid leukemia.
    Tse WW; Zang SL; Bunting KD; Laughlin MJ
    Bone Marrow Transplant; 2008 Mar; 41(5):465-72. PubMed ID: 18246116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced-intensity conditioning and umbilical cord blood transplantation in adults.
    Cutler C; Ballen K
    Bone Marrow Transplant; 2009 Nov; 44(10):667-71. PubMed ID: 19802028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of unrelated cord blood transplants and allogeneic-related hematopoietic stem cell transplants in children with high-risk acute lymphocytic leukemia.
    Jacobsohn DA; Hewlett B; Ranalli M; Seshadri R; Duerst R; Kletzel M
    Bone Marrow Transplant; 2004 Nov; 34(10):901-7. PubMed ID: 15361908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Umbilical cord blood as a source of stem cells].
    Bojanić I; Golubić Cepulić B
    Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelated umbilical cord blood transplantation in children and adults.
    Koh LP
    Ann Acad Med Singap; 2004 Sep; 33(5):559-69. PubMed ID: 15531950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity.
    Johnston L
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):177-92. PubMed ID: 18503985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
    Beam D; Poe MD; Provenzale JM; Szabolcs P; Martin PL; Prasad V; Parikh S; Driscoll T; Mukundan S; Kurtzberg J; Escolar ML
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):665-74. PubMed ID: 17531776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into cord blood stem cell transplantation.
    Tse W; Bunting KD; Laughlin MJ
    Curr Opin Hematol; 2008 Jul; 15(4):279-84. PubMed ID: 18536563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.
    Aversa F; Reisner Y; Martelli MF
    Blood Cells Mol Dis; 2004; 33(3):294-302. PubMed ID: 15528148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation.
    Champlin R; Khouri I; Anderlini P; Gajewski J; Kornblau S; Molldrem J; Shimoni A; Ueno N; Giralt S
    Bone Marrow Transplant; 2001 May; 27 Suppl 2():S13-22. PubMed ID: 11436116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cord blood transplantation for adults.
    Brunstein CG; Wagner JE
    Vox Sang; 2006 Oct; 91(3):195-205. PubMed ID: 16958831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult umbilical cord blood transplantation: a comprehensive review.
    Schoemans H; Theunissen K; Maertens J; Boogaerts M; Verfaillie C; Wagner J
    Bone Marrow Transplant; 2006 Jul; 38(2):83-93. PubMed ID: 16751788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches for improving engraftment after cord blood transplantation.
    Rocha V; Broxmeyer HE
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S126-32. PubMed ID: 19896543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
    Foss FM
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies.
    Rocha V; Mohty M; Gluckman E; Rio B; ; ;
    Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S31-4. PubMed ID: 19561411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.